Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Actualités Accéder au fil d'actualités

SenzaGen achieves 13% revenue growth in second quarter thanks to recovery at VitroScreen

SenzaGen reports a 13% increase in revenue in the second quarter to SEK 15.3 million, driven by a recovery at subsidiary VitroScreen and two large orders. The operating loss narrowed, earnings per share improved compared with the previous year, and operating cash flow was positive. The company maintained a stable gross margin, cited effective cost management, and expects EU regulations reducing animal testing to support long-term demand for its test solutions. » Plus sur de.investing.com

Au dernier trimestre, SENZAGEN AB a réalisé un chiffre d'affaires de 1,38 M € et un bénéfice net de -200,15 k €